CompletedNot Applicable

Impact of Microbiome in Endometriosis Development

Guadeloupe48 participantsStarted 2020-11-25

Plain-language summary

Endometriosis is a chronic disease, of which the pathophysiology is still unknown. Several theories exist, the one of menstrual blood flow has been retained until now but does not fully explain it. The main symptoms are dysmenorrhea, dyspareunia and infertility. The aim of this study is to evaluate the impact of c.albicans colonization of vaginal microbioma in development of endometriosis

Who can participate

Age range18 Years – 50 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: For cases : aged 18-50 years old With confirmed or highly suspected endometriosis Affiliated to a social security system For controls: -aged 18-50 years old No confirmed or highly suspected Affiliated to a social security system Exclusion Criteria: Minors; Pregnant women; Protected persons, or persons placed under the protection of justice; Refusal to participate

What they're measuring

vaginal dysbiosis with C. albicans

Timeframe: At inclusion

Trial details

NCT IDNCT07576361

SponsorCentre Hospitalier Universitaire de la Guadeloupe

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-11-17

View on ClinicalTrials.gov More Endometriosis trials